Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
Kalpathy-Cramer, Jayashree, Chandra, Vyshak, Da, Xiao, Ou, Yangming, Emblem, Kyrre E., Muzikansky, Alona, Cai, Xuezhu, Douw, Linda, Evans, John G., Dietrich, Jorg, Chi, Andrew S., Wen, Patrick Y., Stufflebeam, Stephen, Rosen, Bruce, Duda, Dan G., Jain, Rakesh K., Batchelor, Tracy T., Gerstner, Elizabeth R.
Published in Journal of neuro-oncology (01.02.2017)
Published in Journal of neuro-oncology (01.02.2017)
Get full text
Journal Article